The following sites are concerned with tracking potential adverse reactions to currently approved drugs, aka “pharmacovigilance”.
“Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.” – What is Pharmacovigilance
For an adverse event (AE) to be deemed an adverse drug reaction (ADR) proof of causation is required.
Adverse Event (AE)
“Any untoward medical occurrence in a patient or clinical investigation
subject administered a pharmaceutical product and which does not
necessarily have to have a causal relationship with this treatment.” – ICH E2A
Adverse Drug Reaction (ADR) – for marketed medicinal products
“A response to a drug which is noxious and unintended and which occurs
at doses normally used in man for prophylaxis, diagnosis, or therapy of
disease or for modification of physiological function.” – ICH E2A
FDA Adverse Event Reporting System (FAERS)
“The FDA Adverse Event Reporting System (FAERS) is a database that contains adverse event reports*, medication error reports, and product quality complaints submitted to FDA. The database is designed to support the FDA’s post-marketing safety surveillance program for drug and therapeutic biologic products.” – FAERS
* In FAERS, adverse reactions potentially related to the use of a prescription drug are called “adverse events”.
“FAERS is a useful tool for FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer’s compliance to reporting regulations and responding to outside requests for information. The reports in FAERS are evaluated by clinical reviewers to monitor the safety of products after they are approved by FDA.” – How does the FDA use FAERS?
FAERS uses MEDRA terminology – See below for a description of MEDRA
“For purposes of prescription drug labeling, an adverse reaction is an undesirable effect, reasonably associated with the use of a drug, that may occur as part of the pharmacological action of the drug or may be unpredictable in its occurrence. This definition does not include all adverse events observed during use of a drug, only those for which there is some basis to believe there is a causal relationship between the drug and the occurrence of the adverse event.” – FDA Guidance – Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products
By law, pharmaceutical companies are required to review and report adverse events to the FDA. Serious and unexpected adverse experiences must be reported within 15 calendar days (“Alert Report”); an investigation and follow-up report is required for these events. Code of Federal Regulations – § 314.80 Postmarketing reporting of adverse drug experiences.
FDA announces FAERS will be updated daily (previously updated quarterly) – August 22, 2025
FAERS Dashboard
“The FAERS Public Dashboard is a highly interactive web-based tool that will allow for the querying of FAERS data in a user friendly fashion. The intention of this tool is to expand access of FAERS data to the general public to search for information related to human adverse events reported to the FDA by the pharmaceutical industry, healthcare providers and consumers.” – About
How to Use the FAERS Public Dashboard
A quick example (step-by-step slides in Scribe) of accessing data in FAERS. “Official” video tutorials below.
Example – “Search” for Zepbound, view “Cases by Reaction”, “Reaction Group”, “Reaction” (in this case Nausea), and limit by “Serious”. Right-click on resulting data table to save in the file format of your choice.
General procedure for querying FAERS. See example above!
- Access the Dashboard: Go to the FAERS Public Dashboard.
- Accept the Disclaimer: Upon entering, you’ll encounter a disclaimer about the data’s limitations. Read and accept it to proceed.
- Search for a Drug:
- Click on the “Search” tab.
- Enter the generic or brand name of the drug in the search bar.
- Select the appropriate drug from the dropdown list that appears.
- View Adverse Events:
- After selecting the drug, the dashboard will display various data visualizations.
- To see a list of reported adverse events, click on the “Listing of Cases” tab.
- This section presents a table of adverse events, showing the number of reports for each event associated with the selected drug.
- Filter and Export Data:
- Use available filters to narrow down data by demographics, report type, seriousness, and more.
- You can export the data for further analysis by clicking on the export options provided.
FAERS Overview and Navigation Tutorials
The FDA Adverse Event Reporting System (FAERS) Overview video offers a general introduction to the FAERS system, including data types and case report navigation, which can be useful for understanding the basics before diving into detailed use
FDA Tutorial (2020) – FDA Adverse Event Reporting System (FAERS) Overview.
FDA Tutorial (2018) and Companion slides (download) – Older presentation with excellent companion slides.
MedDRA Terminology
FAERS codes adverse events and medication errors using the Medical Dictionary for Regulatory Activities (MedDRA) terminology.
MedDRA is a hierarchical system for succinctly describing disease signs and symptoms, arranged from very specific to very general. Description of MedDRA from Wikipedia.
MedDRA Hierarchy
MeDRA Terms for Stomach ache
- System Organ Class (SOC)
- High-Level Group Terms (HLGT)
- High-Level Terms (HLT)
- Preferred Terms (PT)
- Lowest Level Terms (LLT)
- Gastrointestinal disorders
- Gastrointestinal signs and symptoms
- Abdominal pain and discomfort
- Abdominal pain
- Stomach ache/gastralgia
The Therapeutics Medicine Administration of Australia has an excellent description of the MedDRA heirarchy – MedDRA – Australia.
OpenVigil has a searchable list of MedDRA preferred terms – MedDRA Preferred Terms
Analyses of FAERS Data
Despite disclaimers, there were over 800 papers published last year that used FAERS to interogate adverse events in marketed medicines, including drawing conclusions explicitly discouraged in the disclaimers.
FAERS disclaimers include…
- The incidence or prevalence of an event cannot be determined from this reporting system alone.
- The information on this website does not confirm a causal relationship between the drug product and the reported adverse event(s).
- FAERS data alone cannot be used to establish rates of events, evaluate a change in event rates over time, or to compare event rates between drug products (see this paper for reasons why).
Recent Studies using FAERS to Assess Drug Safety
- Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database (2025)
- Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database (2024)
- Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database (2024)
- Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration (2024)

“AERSMine is a multi-cohort analyzing application designed to mine data across millions of patient reports (currently 21,560,354 from the FDA’s Adverse Event Reporting System.” – AERSMine Home
Example datasets – Three example datasets are provided in the top right corner of the webpage. For each example, click ‘Load Sample’; once loaded, click ‘Run Analysis’ (at bottom of page).
Paywalled article describing AERSMine methodology – Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data (2016)

User = ur
Password = welcome!
OpenVigil 1, OpenVigil 2, and OpenVigilFDA are web-based application(s) designed for interrogating the FDA Adverse Event Reporting System (AERS) database.
OpenVigil 2 is the most accesible and appropriate version for general use. OpenVigil 1 is essentially obsolete but remains functional.
The abstact from the academic paper introducing OpenVigilFDA provides this general description of the capabilities of the OpenVigil apps.
“OpenVigilFDA provides disproportionality analyses1 to:
- Identify the drug most likely evoking a new adverse event
- Compare two drugs concerning their safety profile
- Check arbitrary combinations of two drugs for unknown drug-drug interactions
- Enhance the relevance of results by identifying confounding factors and eliminating them using background correction”2
1 Paywalled article describing OpenVigil methodology – Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (2001) – Cited >1700 times (Google Scholar)
2 OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications (2016)” – Cited >225 times (Google Scholar)
Submitting Adverse Events to FAERS
Medwatch
“MedWatch is the FDA’s program for reporting serious reactions, product quality problems, therapeutic inequivalence/failure, and product use errors with human medical products, including drugs, biologic products, medical devices, dietary supplements, infant formula, and cosmetics.” – Reporting Serious Problems
- Health Professional Report – FDA Form 3500
- Consumer/Patient Report – FDA Form 3500B
MedWatch, Your Report Can Make a Difference – FDA Podcast
Rest of World AE Reporting Systems
Canada – CVAR and Medeffect
The Canada Vigilance Adverse Reaction (CVAR) online database.
EU – EudraVigilance
Searchable side effects database.
“The information on this website relates to suspected side effects , i.e. medical events that have been observed following the use of a medicine, but which are not necessarily related to or caused by the medicine.” – Eudra Home
Other Pharamcovigilance Tools

eHealthMe’s tagline is “Data-driven phase IV clinical trials”.
“Traditional phase IV clinical trials look for side effects that were not seen before the drugs were approved to the market, and also study how well the drugs work over a long period of time. Only 2,000 phase IV trials are run every year due to intrinsic complexity and prohibitive costs.
By using innovative AI/ML algorithms and models, and medical big data, eHealthMe is able to run millions of data-driven phase IV clinical trials continuously at a fraction of the cost of one traditional trial. Our results are open to the public so everyone can check their drugs in the real world. Specifically, you can get personalized medications, early detection of rare side effects, and prediction of adverse outcomes on eHealthMe.” – Homepage


